Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

QoL

Unmet needs and emerging treatments in von Willebrand disease 2:33
Unmet needs and emerging treatments in von Willebrand disease
Caterina Casari • 26 Jun 2023
Life with Glanzmann’s thrombasthenia: the Glanzmann’s 360 study 0:56
Life with Glanzmann’s thrombasthenia: the Glanzmann’s 360 study
Kate Khair • 27 Jun 2023
Current unmet needs in ITP: impaired quality of life & chronic disorders 2:06
Current unmet needs in ITP: impaired quality of life & chronic disorders
Paolo Gresele • 27 Jun 2023
Quality of life with octocog alfa in patients with hemophilia A: read-out of the AHEAD study 0:42
Quality of life with octocog alfa in patients with hemophilia A: read-out of the AHEAD study
Kate Khair • 27 Jun 2023
Unmet needs in polycythemia vera: improving symptoms & qualify of life 2:57
Unmet needs in polycythemia vera: improving symptoms & qualify of life
Haifa Kathrin Al-Ali • 11 Jun 2023
Health-related quality of life with zanubrutinib versus ibrutinib for patients with R/R CLL 1:20
Health-related quality of life with zanubrutinib versus ibrutinib for patients with R/R CLL
Barbara Eichhorst • 14 Jun 2023
Results from AGILE: ivosidenib-azacitidine vs azacitidine-placebo in patients with IDH1m AML 5:02
Results from AGILE: ivosidenib-azacitidine vs azacitidine-placebo in patients with IDH1m AML
Vidhya Murthy • 19 May 2023
Evaluating the correlation between sleep and QoL in patients with sickle cell disease 1:02
Evaluating the correlation between sleep and QoL in patients with sickle cell disease
Sanne Lugthart • 24 Apr 2023
Optimizing care and improving quality of life in pediatric patients with sickle cell disease 2:46
Optimizing care and improving quality of life in pediatric patients with sickle cell disease
Subarna Chakravorty • 24 Apr 2023
Current and emerging unmet needs in R/R multiple myeloma: improving QoL & novel therapeutic options 1:41
Current and emerging unmet needs in R/R multiple myeloma: improving QoL & novel therapeutic options
Karthik Ramasamy • 25 Apr 2023
Optimizing the outcomes of patients with acute and chronic GvHD & recent updates in this space 1:41
Optimizing the outcomes of patients with acute and chronic GvHD & recent updates in this space
Catherine Lee • 7 Mar 2023
The need to improve the quality of life of patients with AML undergoing alloSCT 2:17
The need to improve the quality of life of patients with AML undergoing alloSCT
Charles Craddock • 10 Dec 2022
Long-term outcomes of patients with TDT treated with beti-cel 12:53
Long-term outcomes of patients with TDT treated with beti-cel
Franco Locatelli • 10 Dec 2022
The association between transfusion independence and improved survival in myelofibrosis 1:30
The association between transfusion independence and improved survival in myelofibrosis
Ruben Mesa • 9 Dec 2022
Assessing & improving the symptoms of patients with MPNs 2:12
Assessing & improving the symptoms of patients with MPNs
Lucia Masarova • 10 Dec 2022
Long-term follow-up of allogeneic stem cell transplantation with omidubicel 6:52
Long-term follow-up of allogeneic stem cell transplantation with omidubicel
Chenyu Lin • 5 Oct 2022

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals